Columba McMenamin

W​e create supplements as they should be – easy to absorb, with proven clinical benefits. Our first product, ATERONON HEART+, was developed through £12 million in research funding and ​was clinically ​tested at Cambridge University Hospital NHS Foundation Trust to ​prove its effectiveness. Every Cambridge Nutraceuticals product is the focus of multiple clinical trials and is manufactured using ​the highest quality ingredients. TURMERIC+, the most popular of our Joint Health supplements and the focus of significant press coverage, is now supported by 41 published studies. Based in Cambridge, ​the world-famous research hub, Cambridge Nutraceuticals was founded in 2012 and has grown ​rapidly, winning the confidence of customers, investors​ and internationally renowned research groups​. We sell direct-to-customer within the UK and reach international purchasers through our overseas distributors, with Australia being ​an especially important market.

Enval is at the forefront of addressing the challenges posed by flexible and multilayer plastic packaging traditionally deemed unrecyclable. Our mission is to transform these materials into valuable resources, eliminating the need to be sent to landfills or incineration. A cornerstone of our expertise lies in recycling laminated packaging waste, with or without an aluminium layer. Our innovative technology extracts high-quality aluminium (where present), oil, and gas from items like baby food and pet food pouches. This process not only ensures comprehensive recycling but also makes it economically sustainable. Our first plant is now operational in Mexico, transforming material previously destined for landfill into a product for new plastic production. Our tests have consistently demonstrated the adaptability of our process across various types of flexible plastic packaging, sourced from both post-consumer and post-production origins

We are a business born out of a global environmental crisis. We are convinced that a combination of technology, innovation and determination can make a true difference in the world we live in today. We live and breathe the reduce, reuse, recycle mantra and we believe that plastic is a great material and an integral part of the solution to reducing our carbon footprint. Our mission is to accelerate the evolution of plastic into a more sustainable material through innovation and technical excellence. Our vision is to be a global force driving positive change towards a sustainable future. CAREERS AT RECYCLING TECHNOLOGIES: Were looking for people who think differently. We want people that like to get involved and are looking to make a real impact for the future. We have an exceptional team of vibrant personalities and international backgrounds. If you want to inspire, be inspired and work in a highly innovative environment. Watch our videos at www.recyclingtechnologies.co.uk/careers

We’re a venture capital firm that uses data and diversification to maximise return potential. To do this we created the Access EIS fund: a uniquely data-driven approach to investing in startups that co-invests with the business angels we’ve identified as the best performers in the UK to gain access to the most promising investment opportunities. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong.

Lombard Private Clients helps entrepreneurs & private client families achieve financial freedom & wellbeing. Driven by the values of Clarity, Simplicity and Impact – we apply these 3 principles to plan for your secure financial future, putting you in control of your financial independence. Our clients are individuals that have a stake or ownership in what they do: o Entrepreneurs & Business Owners o Affluent families & C-suite professionals o Limited Liability Partnerships Take our 360 Exit Review that provides you with a benchmark report that’s personalised to your business. This report will: o Give you clarity as to how ‘exit ready’ you are right now o Highlight the critical factors that will influence your exit valuation o And a snapshot current valuation Take the 360 Exit Review here: https://www.lombardprivateclients.co.uk/about/business-exit-strategy Get in touch with us: ✉️ columba.mcmenamin@sjpp.co.uk | 💻 lombardprivateclients.co.uk 𝐸𝑥𝑖𝑡 𝑠𝑡𝑟𝑎𝑡𝑒𝑔𝑖𝑒𝑠 𝑚𝑎𝑦 𝑖𝑛𝑐𝑙𝑢𝑑𝑒 𝑡ℎ𝑒 𝑟𝑒𝑓𝑒𝑟𝑟𝑎𝑙 𝑡𝑜 𝑠𝑒𝑟𝑣𝑖𝑐𝑒𝑠 𝑡ℎ𝑎𝑡 𝑎𝑟𝑒 𝑠𝑒𝑝𝑎𝑟𝑎𝑡𝑒 𝑎𝑛𝑑 𝑑𝑖𝑠𝑡𝑖𝑛𝑐𝑡 𝑡𝑜 𝑡ℎ𝑜𝑠𝑒 𝑜𝑓𝑓𝑒𝑟𝑒𝑑 𝑏𝑦 𝑆𝑡. 𝐽𝑎𝑚𝑒𝑠𝑠 𝑃𝑙𝑎𝑐𝑒 𝐿𝑜𝑚𝑏𝑎𝑟𝑑 𝑃𝑟𝑖𝑣𝑎𝑡𝑒 𝐶𝑙𝑖𝑒𝑛𝑡𝑠 𝐿𝑡𝑑 𝑖𝑠 𝑎𝑛 𝐴𝑝𝑝𝑜𝑖𝑛𝑡𝑒𝑑 𝑅𝑒𝑝𝑟𝑒𝑠𝑒𝑛𝑡𝑎𝑡𝑖𝑣𝑒 𝑜𝑓 𝑎𝑛𝑑 𝑟𝑒𝑝𝑟𝑒𝑠𝑒𝑛𝑡𝑠 𝑜𝑛𝑙𝑦 𝑆𝑡. 𝐽𝑎𝑚𝑒𝑠𝑠 𝑃𝑙𝑎𝑐𝑒 𝑊𝑒𝑎𝑙𝑡ℎ 𝑀𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡 𝑝𝑙𝑐 (𝑤ℎ𝑖𝑐ℎ 𝑖𝑠 𝑎𝑢𝑡ℎ𝑜𝑟𝑖𝑠𝑒𝑑 𝑎𝑛𝑑 𝑟𝑒𝑔𝑢𝑙𝑎𝑡𝑒𝑑 𝑏𝑦 𝑡ℎ𝑒 𝐹𝑖𝑛𝑎𝑛𝑐𝑖𝑎𝑙 𝐶𝑜𝑛𝑑𝑢𝑐𝑡 𝐴𝑢𝑡ℎ𝑜𝑟𝑖𝑡𝑦) 𝑓𝑜𝑟 𝑡ℎ𝑒 𝑝𝑢𝑟𝑝𝑜𝑠𝑒 𝑜𝑓 𝑎𝑑𝑣𝑖𝑠𝑖𝑛𝑔 𝑠𝑜𝑙𝑒𝑙𝑦 𝑜𝑛 𝑡ℎ𝑒 𝑔𝑟𝑜𝑢𝑝𝑠 𝑤𝑒𝑎𝑙𝑡ℎ 𝑚𝑎𝑛𝑎𝑔𝑒𝑚𝑒𝑛𝑡 𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑠 𝑎𝑛𝑑 𝑠𝑒𝑟𝑣𝑖𝑐𝑒𝑠, 𝑚𝑜𝑟𝑒 𝑑𝑒𝑡𝑎𝑖𝑙𝑠 𝑜𝑓 𝑤ℎ𝑖𝑐ℎ 𝑎𝑟𝑒 𝑠𝑒𝑡 𝑜𝑢𝑡 𝑜𝑛 𝑡ℎ𝑒 𝑔𝑟𝑜𝑢𝑝𝑠 𝑤𝑒𝑏𝑠𝑖𝑡𝑒 𝑤𝑤𝑤.𝑠𝑗𝑝.𝑐𝑜.𝑢𝑘/𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑠 SJP approved 10.09.24

W​e create supplements as they should be – easy to absorb, with proven clinical benefits. Our first product, ATERONON HEART+, was developed through £12 million in research funding and ​was clinically ​tested at Cambridge University Hospital NHS Foundation Trust to ​prove its effectiveness. Every Cambridge Nutraceuticals product is the focus of multiple clinical trials and is manufactured using ​the highest quality ingredients. TURMERIC+, the most popular of our Joint Health supplements and the focus of significant press coverage, is now supported by 41 published studies. Based in Cambridge, ​the world-famous research hub, Cambridge Nutraceuticals was founded in 2012 and has grown ​rapidly, winning the confidence of customers, investors​ and internationally renowned research groups​. We sell direct-to-customer within the UK and reach international purchasers through our overseas distributors, with Australia being ​an especially important market.

Enval is at the forefront of addressing the challenges posed by flexible and multilayer plastic packaging traditionally deemed unrecyclable. Our mission is to transform these materials into valuable resources, eliminating the need to be sent to landfills or incineration. A cornerstone of our expertise lies in recycling laminated packaging waste, with or without an aluminium layer. Our innovative technology extracts high-quality aluminium (where present), oil, and gas from items like baby food and pet food pouches. This process not only ensures comprehensive recycling but also makes it economically sustainable. Our first plant is now operational in Mexico, transforming material previously destined for landfill into a product for new plastic production. Our tests have consistently demonstrated the adaptability of our process across various types of flexible plastic packaging, sourced from both post-consumer and post-production origins

We are a business born out of a global environmental crisis. We are convinced that a combination of technology, innovation and determination can make a true difference in the world we live in today. We live and breathe the reduce, reuse, recycle mantra and we believe that plastic is a great material and an integral part of the solution to reducing our carbon footprint. Our mission is to accelerate the evolution of plastic into a more sustainable material through innovation and technical excellence. Our vision is to be a global force driving positive change towards a sustainable future. CAREERS AT RECYCLING TECHNOLOGIES: Were looking for people who think differently. We want people that like to get involved and are looking to make a real impact for the future. We have an exceptional team of vibrant personalities and international backgrounds. If you want to inspire, be inspired and work in a highly innovative environment. Watch our videos at www.recyclingtechnologies.co.uk/careers

We’re a venture capital firm that uses data and diversification to maximise return potential. To do this we created the Access EIS fund: a uniquely data-driven approach to investing in startups that co-invests with the business angels we’ve identified as the best performers in the UK to gain access to the most promising investment opportunities. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong.